{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:34:55Z","timestamp":1782862495939,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T00:00:00Z","timestamp":1697846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T00:00:00Z","timestamp":1697846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>GHB (gammahydroxybutyrate) and its precursors are popular recreational drugs due to their sedative, anxiolytic and sexually stimulating effects. Their use has been steadily increasing in recent years. The detoxification process is complex and prone to high rates of complications while little is known about the pathophysiology. This study aims to elucidate the characteristics of GHB-addicted patients and to evaluate the risks and complications of GHB withdrawal treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This observational study describes prospectively the socioeconomic status, clinical history and course of inpatient detoxification treatment of a group of 39 patients suffering from GHB substance use disorder. Detoxification treatment took place in a highly specialized psychiatric inpatient unit for substance use disorders.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>GHB patients were characterised by being young, well-educated and by living alone. More than 50% of the patients had no regular income. The patients were male and female in equal numbers. Detoxification treatment was complicated, with high rates of delirium (30.8%) and high need for intensive care (20.5%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In our sample, GHB users were young, well-educated people and male and female in equal number. Detoxification proved to be dangerous for GHB-addicted patients. The presence of delirium and the need for transfer to an intensive care unit during detoxification treatment was extraordinarily high, even with appropriate clinical treatment. The reasons for this remain unknown. Therefore an intensive care unit should be available for GHB detoxification treatment. Further studies are needed to evaluate the options for prophylactic treatment of delirium during detoxification.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13722-023-00414-w","type":"journal-article","created":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T03:16:59Z","timestamp":1697858219000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["GHB: a life-threatening drug complications and outcome of GHB detoxification treatment\u2014an observational clinical study"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6616-6594","authenticated-orcid":false,"given":"Peter","family":"Neu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Danker-Hopfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicitas","family":"Ehlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,21]]},"reference":[{"issue":"1","key":"414_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2174\/1570159X13666141210215423","volume":"13","author":"FP Busard\u00f2","year":"2015","unstructured":"Busard\u00f2 FP, Jones AW. GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome. Curr Neuropharmacol. 2015;13(1):47\u201370. https:\/\/doi.org\/10.2174\/1570159X13666141210215423.","journal-title":"Curr Neuropharmacol"},{"key":"414_CR2","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. European drug report trends and developments. publications office of the European Union. 2018 https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/2420e3dd-6dea-11e8-9483-01aa75ed71a1\/language-en. Accessed Jan 10 2022"},{"key":"414_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.107889","author":"JJ Palamar","year":"2020","unstructured":"Palamar JJ, Keyes KM. Trends in drug use among electronic dance music party attendees in New York City, 2016\u20132019. Drug Alcohol Depend. 2020. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.107889.","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"414_CR4","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3109\/15563650.2015.1115637","volume":"53","author":"AM Dines","year":"2015","unstructured":"Dines AM, Wood DM, Yates C, Heyerdahl F, Hovda KE, Giraudon I, Sedefov R, Dargan PI. Euro-DEN. acute recreational drug and new psychoactive substance toxicity in Europe: 12 months data collection from the European drug emergencies network (Euro-DEN). Clin Toxicol. 2015;53(9):930. https:\/\/doi.org\/10.3109\/15563650.2015.1115637.","journal-title":"Clin Toxicol"},{"issue":"2","key":"414_CR5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1054\/jcfm.2001.0473","volume":"8","author":"C Jones","year":"2001","unstructured":"Jones C. Suspicious death related to gamma-hydroxybutyrate (GHB) toxicity. J Clin Forensic Med. 2001;8(2):74\u20136. https:\/\/doi.org\/10.1054\/jcfm.2001.0473.","journal-title":"J Clin Forensic Med"},{"issue":"1\u20132","key":"414_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2009.04.012","volume":"104","author":"LP Carter","year":"2010","unstructured":"Carter LP, Pardi D, Gorsline J, Griffiths RR. Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): Differences in characteristics and misuse. Drug Alcohol Depend. 2010;104(1\u20132):1\u201310. https:\/\/doi.org\/10.1016\/j.drugalcdep.2009.04.012.","journal-title":"Drug Alcohol Depend"},{"key":"414_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neubiorev.2015.03.012","volume":"53","author":"JM Corkery","year":"2015","unstructured":"Corkery JM, Loi B, Claridge H, Goodair C, Corazza O, Elliott S, Schifano F. Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): a literature review with a focus on UK fatalities related to non-medical use. Neurosci Biobehav Rev. 2015;53:52\u201378. https:\/\/doi.org\/10.1016\/j.neubiorev.2015.03.012.","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"414_CR8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/s0014-2999(02)01502-9","volume":"441","author":"MA Carai","year":"2002","unstructured":"Carai MA, Colobo G, Reali R, Serra S, Mocci I, Castelli MP, Cignarella G, Gessa GL. Central effects of 1.4-butanediol are mediated by GABA(B) receptors via its conversion into gamma-hydroxybutyric acid. European J Pharmacol. 2002;441(3):157\u201363. https:\/\/doi.org\/10.1016\/s0014-2999(02)01502-9.","journal-title":"European J Pharmacol"},{"key":"414_CR9","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/jat\/28.8.625","volume":"28","author":"R Brenneisen","year":"2004","unstructured":"Brenneisen R, Elsohly MA, Murphy TP, Passarrelli J, Russmann S, Salamone SJ, Watson DE. Pharmacokinetics and excretion of gammahydroxybutyrate (GHB) in healthy subjects. J Anal Toxicol. 2004;28:625\u201330. https:\/\/doi.org\/10.1093\/jat\/28.8.625.","journal-title":"J Anal Toxicol"},{"issue":"1","key":"414_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1208\/s12248-020-00543-z","volume":"23","author":"MA Felmlee","year":"2021","unstructured":"Felmlee MA, Morse BL, Morris ME. \u03b3-hydroxybutyric acid pharmacokinetics pharmacodynamics and toxicology. AAPS J. 2021;23(1):22. https:\/\/doi.org\/10.1208\/s12248-020-00543-z.","journal-title":"AAPS J"},{"issue":"1","key":"414_CR11","first-page":"93","volume":"6","author":"MJ Hoes","year":"1980","unstructured":"Hoes MJ, Vree TB, Uelen PJ. Gamma-hydroxybutyric acid as hypnotic. clinical and pharmacokinetic evaluation of gamma-hydroxybutyric acid as hypnotic in man. Encephale. 1980;6(1):93\u20139.","journal-title":"Encephale"},{"issue":"13","key":"414_CR12","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1080\/10826084.2020.1793368","volume":"55","author":"FR Raposo Pereira","year":"2020","unstructured":"Raposo Pereira FR, McMaster MTB, de Vries Y, van den Brink W, van Wingen GA. Demographic and clinical characteristics of regular GHB-users with and without GHB-induced comas. Subst Use Misuse. 2020;55(13):2148\u201355. https:\/\/doi.org\/10.1080\/10826084.2020.1793368.","journal-title":"Subst Use Misuse"},{"issue":"2","key":"414_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000443173","volume":"73","author":"RM Kamal","year":"2016","unstructured":"Kamal RM, Van Noorden MS, Franzek E, Dijkstra BAG, Loonen AJM, DeJong CAJ. The neurobiological mechanisms of gamma-hydroxybutyrate dependence and withdrawal and their clinical relevance: a review. Neuropsychobiology. 2016;73(2):65\u201380. https:\/\/doi.org\/10.1159\/000443173.","journal-title":"Neuropsychobiology"},{"issue":"11","key":"414_CR14","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1002\/gps.4823","volume":"33","author":"JR Maldonado","year":"2018","unstructured":"Maldonado JR. Delirium pathophysiology: an updated hypothesis of the etiology of acute brain failure. Int J Geriatr Psychiatry. 2018;33(11):1428\u201357. https:\/\/doi.org\/10.1002\/gps.4823.","journal-title":"Int J Geriatr Psychiatry"},{"key":"414_CR15","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/dta.292","volume":"3","author":"DM Wood","year":"2011","unstructured":"Wood DM, Brailsford AD, Dargan PI. Acute toxicity and withdrawal syndromes related to gamma-hydroxybutyrate (GHB) and its analogues gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD). Drug Test Anal. 2011;3:417\u201325. https:\/\/doi.org\/10.1002\/dta.292.","journal-title":"Drug Test Anal"},{"issue":"1","key":"414_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/jcph.767","volume":"57","author":"CM White","year":"2017","unstructured":"White CM. Pharmacologic, pharmacokinetic, and clinical assessment of illicitly used \u03b3\u2014hydroxybutyrate. J Clin Pharmacol. 2017;57(1):33\u20139. https:\/\/doi.org\/10.1002\/jcph.767.","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"414_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00228-017-2387-z","volume":"74","author":"CN Floyd","year":"2018","unstructured":"Floyd CN, Wood DM, Dargan PI. Baclofen in gamma-hydroxybutyrate withdrawal: patterns of use and online availability. Eur J Clin Pharmacol. 2018;74(3):349\u201356. https:\/\/doi.org\/10.1007\/s00228-017-2387-z.","journal-title":"Eur J Clin Pharmacol"},{"key":"414_CR18","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.drugalcdep.2015.07.005","volume":"154","author":"A Wong","year":"2015","unstructured":"Wong A, Benedict NJ, Lohr BR, Pizon AF, Kane-Gill SL. Management of benzodiazepine-resistant alcohol withdrawal across a healthcare system: benzodiazepine dose-escalation with or without propofol. Drug Alcohol Depend. 2015;154:296\u20139. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.07.005.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"414_CR19","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/01.pra.0000452567.84825.07","volume":"20","author":"L Ghio","year":"2014","unstructured":"Ghio L, Cervetti A, Respino M, Belvederi M, Amore M. Management and treatment of gamma butyrolactone withdrawal syndrome: a case report and review. J Psychiatry Pract. 2014;20(4):294\u2013300. https:\/\/doi.org\/10.1097\/01.pra.0000452567.84825.07.","journal-title":"J Psychiatry Pract"},{"key":"414_CR20","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association, ed. (2022). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision. Washington, DC, USA: American Psychiatric Publishing. ISBN 978-0890425756.","DOI":"10.1176\/appi.books.9780890425787"},{"issue":"11","key":"414_CR21","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.3390\/jcm10112333","volume":"10","author":"CJH Wolf","year":"2021","unstructured":"Wolf CJH, Beurmanjer H, Dijkstra BAG, Geerlings AC, Spoelder M, Homberg JR, Schellekens AFA. Characterization of the GHB withdrawal syndrome. J Clin Med. 2021;10(11):2333. https:\/\/doi.org\/10.3390\/jcm10112333.","journal-title":"J Clin Med"},{"issue":"1","key":"414_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1177\/0956462416666753","volume":"28","author":"Z Ottaway","year":"2017","unstructured":"Ottaway Z, Finnerty F, Amlani A, Pinto-Sander N, Szanyi J, Richardson D. Men who have sex with men diagnosed with a sexually transmitted infection are significantly more likely to engage in sexualised drug use. Int J STD AIDS. 2017;28(1):91\u20133. https:\/\/doi.org\/10.1177\/0956462416666753.","journal-title":"Int J STD AIDS"},{"issue":"2","key":"414_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1071\/sh17146","volume":"15","author":"MA Hammoud","year":"2018","unstructured":"Hammoud MA, Bourne A, Maher L, Jin F, Haire B, Lea T, Degenhardt L, Grierson J, Prestage G. Intensive sex partying with gamma-hydroxybutyrate: factors associated with using gammahydroxybutyrate for chemsex among Australian gay and bisexual men\u2014results from the flux study. Sexual Health. 2018;15(2):123\u201334. https:\/\/doi.org\/10.1071\/sh17146.","journal-title":"Sexual Health"},{"issue":"1","key":"414_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.drugalcdep.2004.01.012","volume":"75","author":"M McDonough","year":"2004","unstructured":"McDonough M, Kennedy N, Glasper A, Bearn J. Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review. Drug Alcohol Depend. 2004;75(1):3\u20139. https:\/\/doi.org\/10.1016\/j.drugalcdep.2004.01.012.","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"414_CR25","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s40263-020-00730-8","volume":"34","author":"H Beurmanjer","year":"2020","unstructured":"Beurmanjer H, Luykx JJ, De Wilde B, van Rompaey K, Buwalda VJA, De Jong CAJ, Dijkstra BAG, Schellekens AFA. Tapering with pharmaceutical GHB or benzodiazepines for detoxification in GHB-dependent patients: a matched-subject observational study of treatment-as-usual in Belgium and The Netherlands. CNS Drugs. 2020;34(6):651\u20139. https:\/\/doi.org\/10.1007\/s40263-020-00730-8.","journal-title":"CNS Drugs"},{"key":"414_CR26","volume-title":"Essential psychopharmacology neuroscientific basis and practical applications","author":"SM Stahl","year":"2018","unstructured":"Stahl SM. Essential psychopharmacology neuroscientific basis and practical applications. Cambridge: Cambridge University Press; 2018."},{"key":"414_CR27","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/089198879801100304","volume":"11","author":"RC van der Mast","year":"2018","unstructured":"van der Mast RC. Pathophysiology of delirium. J Geriatric Psychiat Neurol. 2018;11:138\u201345.","journal-title":"J Geriatric Psychiat Neurol"},{"issue":"2","key":"414_CR28","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.bcp.2013.10.028","volume":"87","author":"T Bay","year":"2014","unstructured":"Bay T, Eghorn LF, Klein AB, Wellendorph P. GHB receptor targets in the CNS: focus on high-affinity binding sites. Bioch Pharmacol. 2014;87(2):220\u20138. https:\/\/doi.org\/10.1016\/j.bcp.2013.10.028.","journal-title":"Bioch Pharmacol"},{"issue":"4","key":"414_CR29","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1159\/000324873","volume":"17","author":"M Specka","year":"2011","unstructured":"Specka M, Buchholz A, Kuhlmann T, Rist F, Scherbaum N. Prediction of the outcome of inpatient opiate detoxification treatment: results from a multicenter study. Eur Addict Res. 2011;17(4):178\u201384. https:\/\/doi.org\/10.1159\/000324873.","journal-title":"Eur Addict Res"},{"issue":"3","key":"414_CR30","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/alcalc\/37.3.277","volume":"37","author":"J Mart\u00ednez-Raga","year":"2002","unstructured":"Mart\u00ednez-Raga J, Marshall EJ, Keaney F, Ball D, Strang J. Unplanned versus planned discharges from in-patient alcohol detoxification: retrospective analysis of 470 first-episode admissions. Alcohol. 2002;37(3):277\u201381. https:\/\/doi.org\/10.1093\/alcalc\/37.3.277.","journal-title":"Alcohol"},{"key":"414_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/6415831","author":"Y Sofin","year":"2017","unstructured":"Sofin Y, Danker-Hopfe H, Gooren T, Neu P. Predicting inpatient detoxification outcome of alcohol and drug dependent patients: the influence of sociodemographic environment, motivation, impulsivity, and medical comorbidities. J Addict. 2017. https:\/\/doi.org\/10.1155\/2017\/6415831.","journal-title":"J Addict"}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-023-00414-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-023-00414-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-023-00414-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T23:20:03Z","timestamp":1700436003000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/s13722-023-00414-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,21]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["414"],"URL":"https:\/\/doi.org\/10.1186\/s13722-023-00414-w","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,21]]},"assertion":[{"value":"16 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted ethically in accordance with the World Medical Association Declaration of Helsinki. The patients being evaluated prospectively have given their written informed consent and the study protocol was approved by the institute\u2019s committee on human research of Charit\u00e9 Berlin (reference number: EA1\/235\/21).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}